蜘蛛毒的蛋白质溶解稳定导致口服活性生物杀虫剂
Breck R Davis1, Alexandra M Haase1, Joseph S Tourtois1
1Vestaron Crop Protection, Kalamazoo, Michigan, USA.
Pest management science
|June 19, 2025
概括
一种新的蜘蛛毒素被改造成一种稳定,口服活跃的生物杀虫剂. 这种,U1-AGTX-Ta1b-QA,表现出与商业杀虫剂相当的疗效,并经过EPA批准.
科学领域:
- 生物化学 生物化学
- 昆虫学 昆虫学是一门学科.
- 生物技术是生物技术.
背景情况:
- 霍博蜘蛛毒素U1-AGTX-Ta1b被研究其生物杀虫剂潜力.
- 最初的研究表明,注射后具有强烈的杀虫活性,但对Lepidopterans的口服疗效有限.
研究的目的:
- 从U1-AGTX-Ta1b中设计出一种稳定且口服活性的生物杀虫剂.
- 为了克服昆虫肠道蛋白酶带来的局限性,并增强的稳定性.
主要方法:
- 氨酸扫描发现了富含氨酸和氨酸的关键表面补丁.
- 在R9向谷氨 (R9Q) 的位点定向突变生成稳定了.
- 进一步的修改删除了糖化和外蛋白酶位点,以改善表达和稳定性.
主要成果:
- 突变R9Q使U1-AGTX-Ta1b口服活跃,并且温度更稳定.
- 精制的,U1-AGTX-Ta1b-QA,显示出与商业产品相比的杀虫活性.
- 开发的生物杀虫剂适合商业化,并已获得EPA的批准.
结论:
- 一种新的基于的生物杀虫剂 (U1-AGTX-Ta1b-QA) 从蜘蛛毒中成功开发出来.
- 这种生物杀虫剂为虫虫害对化学杀虫剂提供了稳定有效的替代品.
- 美国环保署已批准该用于使用,强调其商业可行性.
更多相关视频
10:25Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
Published on: November 3, 2014
33.9K
10:46A Calcium Bioluminescence Assay for Functional Analysis of Mosquito Aedes aegypti and Tick Rhipicephalus microplus G Protein-coupled Receptors
Published on: April 20, 2011
15.8K
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
